Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas

NCT07448480 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Malignant Glioma
Glioblastoma
Anaplastic Astrocytoma
Pleomorphic Xanthoastrocytoma

Interventions

DRUG: Bevacizumab-Containing Regimens
DRUG: Non-Bevacizumab Regimens
DRUG: BRAF ± MEK Targeted Therapy

Sponsor

Blokhin's Russian Cancer Research Center